ArticlemedRxiv : the preprint server for health sciences2024
SARS-CoV-2 vaccination in the first year after hematopoietic cell transplant or chimeric antigen receptor T cell therapy: A prospective, multicenter, observational study (BMT CTN 2101).
Joshua A Hill et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.